:: Welcome to Alaven -ROWASA (mesalamine) Rectal Suspension::

For Healthcare Professionals
(This site is intended solely for the use of healthcare professionals)

Stay Up-to-Date


*First Name:

*Last Name:

Organization:

*Email:

Mailing Address:

City:

State:

Zip:

Phone Number:

How likely are you to prescribe a rectal suspension as first-line treatment for your patients living with UC? Ranges 1-5 (with 5 being likely) 1 2 3 4 5

Have you previously prescribed a rectal suspension for the soothing relief of flare-ups associated with UC? Yes No

Yes I would like to receive updates on new product information and other GI medical and product news.

What specific information are you interested in? (check all that apply) Product Samples (Form requiring signature immediately sent via e-mail) Sales Representative Visit Patient Assistance Program Patient Materials and Programs Other Alaven Prescription and OTC products

Comments

The current formulation of ROWASA (mesalamine) is approved by the FDA for the treatment of mild to moderate distal ulcerative colitis, proctosigmoiditis, or ulcerative proctitis and is manufactured and marketed by Alaven Pharmaceutical. Click here for full prescribing information >>

© 2008 Alaven™ Pharmaceutical LLC, Marietta, GA. All rights reserved. ROWASA® is a registered trademark of Alaven™ Pharmaceutical LLC.